A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Phase of Trial: Phase III
Latest Information Update: 27 Jun 2018
At a glance
- Drugs Ribociclib (Primary) ; Letrozole
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 19 Jun 2018 Planned End Date changed from 16 Dec 2019 to 14 May 2021.
- 16 Jun 2017 Planned End Date changed from 15 Dec 2019 to 16 Dec 2019.